Roche's VENTANA DP 200 Digital System Approved For Diagnostic Use By FDA
Roche's VENTANA DP 200 Digital System Approved For Diagnostic Use By FDA
羅氏VENTANA DP 200數字系統獲得FDA診斷用途批准。
- The solution, which includes the VENTANA DP 200 slide scanner, Roche's digital pathology workflow software and a display, is now cleared to aid in clinical diagnosis, enabling pathologists to diagnose patients using digital images.
- Primary diagnosis for digital pathology enhances healthcare efficiency and helps ensure effective and timely patient care, especially in areas where access to pathologists is limited.
- This clearance is a foundational step in Roche's commitment to enable routine clinical diagnosis with its digital pathology solutions.
- 包括VENTANA DP 200滑板掃描儀、羅氏數字病理工作流軟件和顯示器的解決方案現已獲准用於臨床診斷，使病理醫師能夠使用數字圖像診斷患者。
- 數字病理的初診增強了醫療效率，有助於保證有效和及時的患者護理，特別是在接觸病理醫師有限的地區。
- 這一清除程序是羅氏致力於通過其數字病理解決方案實現常規臨床診斷的基礎步驟。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。